Unilever Accelerates Wellness Strategy with Grüns Acquisition

Sharing is caring!

Grüns Emerges as a Supplements Powerhouse (Image Credits: Pixabay)

London – Unilever announced an agreement to acquire Grüns, a fast-growing U.S. company specializing in gummy nutritional supplements. The deal underscores the consumer goods giant’s commitment to high-growth sectors amid its ongoing portfolio overhaul. Reports indicate the transaction could be valued at $1.2 billion, though official terms were not disclosed.[1][2]

Grüns Emerges as a Supplements Powerhouse

Grüns launched in 2023 under the leadership of founder Chad Janis, quickly establishing itself in the competitive vitamins, minerals, and supplements market. The company focused on gummy products packed with greens, emphasizing science-backed formulations that prioritize taste and daily adherence. Within two years, Grüns achieved more than $300 million in revenue and ramped up production to ship 10 million gummies each day.[2]

Products reached consumers through direct-to-consumer channels and major retailers such as Amazon, Target, Walmart, and Costco. A Series B funding round in 2025 valued the startup at $500 million, reflecting investor confidence in its trajectory. This momentum positioned Grüns as a leader in the greens supplement category, where enjoyable formats addressed common barriers to consistent use.

Unilever’s Pivot Toward Premium Growth Areas

Unilever has built a robust presence in supplements over the past decade, owning brands like Olly, SmartyPants, and Onnit. The Grüns acquisition arrives shortly after the company agreed to merge its food operations – home to Knorr – with spice producer McCormick in a transaction that valued the division at approximately $44.8 billion.[2] Executives described the move as a step to refine the portfolio around premiumization, beauty, wellbeing, and the U.S. market.

This strategy aligns with broader shifts in consumer preferences toward functional nutrition. Unilever’s wellbeing unit now gains a fresh asset tailored to American tastes and retail dynamics. Key priorities include:

• Expanding in high-growth U.S. channels.
• Enhancing premium product offerings.
• Capitalizing on the booming demand for enjoyable wellness routines.
• Leveraging established distribution networks.

Executive Perspectives on the Partnership

Jostein Solheim, CEO of Unilever’s Wellbeing unit, highlighted Grüns’ unique appeal. “As a leader and true innovator in the Greens Supplement category, what sets Grüns apart is its focused portfolio of science-backed products that people genuinely enjoy, trust, and consistently use,” he stated.[2] Chad Janis echoed this enthusiasm on LinkedIn, noting, “With Unilever behind us, we can reach more people, move faster, and continue raising the bar on what an enjoyable daily wellness habit can be.”[2]

Janis will remain as Grüns’ chief executive post-acquisition, ensuring continuity for the brand. This leadership retention signals confidence in the company’s independent operations under Unilever’s umbrella. The arrangement allows Grüns to maintain its identity while accessing global scale.

Timeline and Path Forward

The acquisition awaits regulatory approvals and is slated to close later in 2026. Financial details beyond the reported $1.2 billion figure have not surfaced publicly.[1] For context, the table below outlines Grüns’ key milestones:

Integration promises accelerated expansion, blending Grüns’ innovation with Unilever’s resources. Investors reacted mildly, with shares showing slight movement post-announcement.

This transaction highlights the wellness sector’s allure for legacy giants seeking reinvention. As Unilever sharpens its edge in wellbeing, Grüns stands poised for broader reach. What implications do you see for the supplements industry? Share your thoughts in the comments.